Skip to content
OpenCapital
Get started

Medpace Holdings, Inc. MEDP Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Veeva Systems logo
Veeva SystemsVEEV
——
Medline, Inc. logo
Medline, Inc. MDLN
——
Guardant Health logo
Guardant HealthGH
——

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Medpace Holdings, Inc. (MEDP) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $224.33 in Q1 2026.
How has Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 19.6% year-over-year, from $187.57 to $224.33.
What is the long-term trend for Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 32.6% compound annual growth rate (CAGR), from $68.39 to $211.29.